| Item | Cat. No. | Application | Isotype |
| Anti-IL-5 [SB-240563 (Mepolizumab)] (MABL-3709) | MABL-3709 | therapeutic | Engineer antibody |
| Anti-IL-5 [Sch 55700 (Reslizumab)] (MABL-3710) | MABL-3710 | inhibit, neutralize, therapeutic, Block | Engineer antibody |
| Anti-IL-6 receptor [rhPM-1 (Tocilizumab)] (MABL-3711) | MABL-3711 | inhibit, ELISA | Engineer antibody |
| Anti-Integrin alpha 4 [Natalizumab] (MABL-3712) | MABL-3712 | Block, FC | Engineer antibody |
| Anti-Integrin alpha-4/beta-7 [Vedolizumab (LDP-02)] (MABL-3713) | MABL-3713 | therapeutic, FC | Engineer antibody |
| Anti-Lymphotoxin alpha [MLTA3698A (Pateclizumab)] (MABL-3714) | MABL-3714 | IP, Block, FC | Engineer antibody |
| Anti-OX40L [R4930 (Oxelumab)] (MABL-3715) | MABL-3715 | Block, FC | Engineer antibody |
| Anti-oxLDL [2-DO3] (MABL-3716) | MABL-3716 | ELISA | Engineer antibody |
| Anti-PD-1 [5C4.B8 (Nivolumab)] (MABL-3717) | MABL-3717 | SPR, Block, FC, IHC | Engineer antibody |
| Anti-RSV [RSHZ19 (Felvizumab)] (MABL-3718) | MABL-3718 | functional, ELISA | Engineer antibody |
| Anti-TAG-72 [Minretumomab (CC49 )] (MABL-3719) | MABL-3719 | RIA, therapeutic, WB, FC, IHC | Engineer antibody |
| Anti-Tenascin [I-81C6 (Neuradiab)] (MABL-3720) | MABL-3720 | cross-competition assay, immunoreactivity, radioiodination, ELISA | Engineer antibody |
| Anti-TNF alpha [cA2 (Infliximab)] (MABL-3721) | MABL-3721 | in vivo, ELISA, FC | Engineer antibody |
| Anti-TNF alpha [CDP 571 (Humicade)] (MABL-3722) | MABL-3722 | NTRL, ELISA | Engineer antibody |
| Anti-TNF alpha [D2E7 (Adalimumab)] (MABL-3723) | MABL-3723 | Blocking, ELISA, IF, IHC | Engineer antibody |
| Anti-TRP-1, gp75 [TA99] (MABL-3724) | MABL-3724 | IP, WB, ELISA, FC, IF, IHC-Fr | Engineer antibody |
| Anti-Tumor associated glycoprotein (TAG) 72 [B72.3 (Satumomab)] (MABL-3725) | MABL-3725 | FC, IHC, Imaging | Engineer antibody |
| Anti-V(beta)3 TCR [JOVI.1] (MABL-3726) | MABL-3726 | FACS, IP, IF, IHC | Engineer antibody |
| Anti-VEGF [Bevacizumab] (MABL-3727) | MABL-3727 | IP, WB, Block, ELISA, FC | Engineer antibody |
| Anti-Amyloid beta A4 protein [LY2062430 (Solanezumab, hu266)] (MABL-3728) | MABL-3728 | therapeutic, ELISA | Engineer antibody |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
